CDER New August 6, 2015

What's New on the FDA Drugs Site

August 5, 2015

• Brief Summary and Adequate Directions for Use: Disclosing Risk Information in Consumer-Directed Print Advertisements and Promotional Labeling for Prescription Drugs Guidance for Industry (PDF - 304KB)
• Drug Firm Annual Registration Status (updated)
• Drug Firm Annual Registration Status Download File (updated)
• Drug Trials Snapshots:
  • REXULTI: For the treatment of major depressive disorder 
  • REXULTI: For the treatment of schizophrenia
• Drugs@FDA Data Files (updated)
• National Drug Code Directory
• Paragraph IV Patent Certifications (updated)